Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 05, 2023

SELL
$196.41 - $258.77 $453,903 - $598,017
-2,311 Reduced 1.61%
141,385 $27.8 Million
Q2 2023

Jul 10, 2023

SELL
$232.06 - $274.11 $1.36 Million - $1.61 Million
-5,881 Reduced 3.93%
143,696 $34.8 Million
Q1 2023

May 05, 2023

BUY
$222.88 - $262.22 $7.09 Million - $8.34 Million
31,808 Added 27.01%
149,577 $37.9 Million
Q1 2023

Apr 27, 2023

SELL
$222.88 - $262.22 $6.74 Million - $7.93 Million
-30,243 Reduced 20.43%
117,769 $29.8 Million
Q4 2022

Jan 30, 2023

BUY
$188.57 - $253.75 $1.52 Million - $2.05 Million
8,083 Added 5.78%
148,012 $36.9 Million
Q3 2022

Oct 18, 2022

SELL
$201.46 - $267.32 $11.3 Million - $15 Million
-55,979 Reduced 28.57%
139,929 $28.2 Million
Q2 2022

Jul 13, 2022

BUY
$244.93 - $354.82 $746,791 - $1.08 Million
3,049 Added 1.58%
195,908 $48.2 Million
Q1 2022

Apr 11, 2022

BUY
$295.56 - $354.83 $22.2 Million - $26.6 Million
75,090 Added 63.76%
192,859 $68.4 Million
Q4 2021

Jan 19, 2022

BUY
$289.48 - $383.27 $2.83 Million - $3.75 Million
9,783 Added 9.06%
117,769 $38.7 Million
Q3 2021

Oct 22, 2021

BUY
$360.3 - $422.82 $9.35 Million - $11 Million
25,958 Added 31.65%
107,986 $40.7 Million
Q2 2021

Jul 13, 2021

BUY
$385.96 - $443.85 $7.81 Million - $8.98 Million
20,232 Added 32.74%
82,028 $33 Million
Q1 2021

Apr 29, 2021

BUY
$372.25 - $429.44 $126,937 - $146,439
341 Added 0.55%
61,796 $25.7 Million
Q4 2020

Jan 19, 2021

BUY
$318.23 - $411.57 $2.81 Million - $3.63 Million
8,827 Added 16.77%
61,455 $25.3 Million
Q3 2020

Nov 09, 2020

BUY
$326.7 - $408.18 $6.11 Million - $7.63 Million
18,701 Added 55.12%
52,628 $17.9 Million
Q2 2020

Jul 17, 2020

BUY
$279.8 - $376.58 $9.49 Million - $12.8 Million
33,927 New
33,927 $12.3 Million

Others Institutions Holding TFX

About TELEFLEX INC


  • Ticker TFX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,906,400
  • Market Cap $8.1B
  • Description
  • Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access ...
More about TFX
Track This Portfolio

Track Sarasin & Partners LLP Portfolio

Follow Sarasin & Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sarasin & Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Sarasin & Partners LLP with notifications on news.